Form D · Biotechnology
PBS Biotech, Inc.
Camarillo, CA · CIK 0001962718
Offering snapshot reported Sep 24, 2024 · SEC filing
- Reported sold
- $8.5M Offering amount: $17M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 11, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 24, 2024 | Initial | $8,499,999 | No comparison | 3 | SEC filing |
| Jan 20, 2023 | Initial | $34,706,776 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-524806
Source: Form D, filed Sep 24, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nelson Bermudez | Executive |
| Matt Croughan | Executive |
| Dennis Fenton | Director |
| Leland Foster | Director |
| Daniel Friedman | Director |
| Brian Lee | Director, Executive |
| Xiaoshen Liao | Director |
| Xiaoshen (Jerry) Liao | Director |
| Jung Lim | Director |
| Terrell Mathews | Executive |
| Bryan Poltilove | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4721 Calle Carga
Camarillo, CA, 93012
Camarillo, CA, 93012